Anondita Medi Stock Price Today (NSE: ANONDITA)

Anondita Medi

1084.60+0.90 (+0.08%)
Market Closed

Fundamental Score

...

Anondita Medi Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Anondita Medi share price today is 1084.60, up +0.08% on NSE/BSE as of 22 September 2026. Anondita Medi (ANONDITA) is a Small-cap company in the Personal Care sector with a market capitalisation of 2.14K (Cr). The 52-week high for ANONDITA share price is 1267.95 and the 52-week low is 416.05. At a P/E ratio of 63.95x, ANONDITA is currently trading above its industry average P/E of 40.63x. The company has a Return on Equity (ROE) of 40.03% and a debt-to-equity ratio of 0.26.

Anondita Medi Share Price Chart — NSE/BSE Historical Performance

No data
High
1190.00
Low
997.50
Volume
69.1K
Change
+7.80%

Anondita Medi share price chart: 7.80% return over the past month. 52-week high ₹1267.95, 52-week low ₹416.05.

Anondita Medi — Last 10 Trading Days

DateOpenHighLowCloseVolume
1090.551105.001080.101083.7053.00K (Cr)
1125.001125.051082.001090.5582.20K (Cr)
1165.001180.001106.751124.001.06L (Cr)
1154.901184.001112.001158.0565.80K (Cr)
1133.101158.001078.751140.9058.40K (Cr)
1110.001164.501100.151129.5552.80K (Cr)
1125.051152.301093.001128.401.09L (Cr)
1142.001171.951102.101144.3559.40K (Cr)
1179.001190.001130.051178.6089.40K (Cr)
1110.001182.951110.001147.9068.80K (Cr)

Anondita Medi — Last 12 Months Price History

MonthOpenHighLowCloseChange
1090.001190.001041.051083.70-0.58%
1060.201174.00997.501075.50+1.44%
1194.951267.951050.101088.75-8.89%
1042.801100.001042.801097.60+5.26%
1000.001050.00911.801013.25+1.32%
715.801190.00715.801020.30+42.54%
697.00720.00634.50658.75-5.49%
906.00906.00783.75787.65-13.06%
992.05992.05952.85952.85-3.95%
672.05952.80672.05942.35+40.22%
630.00675.80577.20621.80-1.30%
420.00439.00416.05434.00+3.33%

Returns & Performance

Excellent

Return on Equity (ROE)

40.03%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

43.60%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Anondita Medi Valuation Check

Poor

Price to Earnings (P/E)

63.95x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

40.63x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

62.40%

% shares held by company founders/management

Poor

FII Holding

3.40%

% shares held by foreign institutional investors

Average

DII Holding

5.70%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

85.87%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

82.76%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.26x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

14.25x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Anondita Medi Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ANONDITA across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Strong Return on Equity (40.03%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (43.60%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Robust Profit Growth (85.87%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (82.76%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.26)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (14.25x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (62.40%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Premium Valuation Risk (P/E: 63.95x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Limited Institutional Interest (FII+DII: 9.10%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Anondita Medi vs Personal Care Peers

Peer Comparison - Personal Care

Compare Anondita Medi with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
44.6/100
1085
₹2139.01
64.0
Average
40.03%
Excellent
43.60%
Excellent
0.3
Excellent
0.00%
51.3/100
857
₹87647.31
45.8
Average
15.10%
Good
22.16%
Excellent
0.3
Excellent
1.58%
Average
6.60%
Good
1.90%
48.2/100
370
₹65638.00
33.3
Average
17.06%
Good
21.26%
Excellent
0.1
Excellent
2.28%
Average
6.65%
Good
1.91%
52.6/100
1803
₹49052.48
36.4
Average
81.59%
Excellent
104.96%
Excellent
0.0
Excellent
5.06%
Good
4.51%
Average
2.54%
62.9/100
271
₹36480.65
99.7
Average
27.30%
Excellent
35.38%
Excellent
0.1
Excellent
30.15%
Excellent
20.00%
Excellent
0.00%
55.6/100
7647
₹24822.16
31.4
Average
114.93%
Excellent
136.60%
Excellent
0.0
Excellent
14.51%
Good
7.40%
Good
2.61%
70.7/100
7502
₹24449.02
36.6
Average
66.44%
Excellent
81.46%
Excellent
0.0
Excellent
23.18%
Excellent
13.04%
Good
2.30%
41.7/100
373
₹16259.63
21.7
Average
27.60%
Excellent
29.94%
Excellent
0.0
Excellent
11.26%
Good
5.58%
Good
2.43%
59.7/100
468
₹15225.12
61.2
Average
15.43%
Good
19.16%
Good
0.0
Excellent
16.57%
Excellent
39.06%
Excellent
0.00%
62.3/100
512
₹6682.42
30.6
Average
0.00%
Poor
30.53%
Excellent
0.0
Excellent
-3.53%
Poor
4.79%
Average
0.00%
50.6/100
144
₹215.35
73.4
Average
14.50%
Average
19.31%
Good
0.0
Excellent
17.81%
Excellent
12.93%
Good
0.32%

Anondita Medi Quarterly Performance

Latest quarterly metrics for ANONDITA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

82.76%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

85.87%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Anondita Medi Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ANONDITA — calculated from daily price history

70RSI 14
Neutral — RSI 70

Momentum is balanced — neither overbought nor oversold.

SMA 50
1052
▲ Price above SMA 50 — Short-term bullish
30-Day Avg Volume
58K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Anondita Medi Financial Statements

Annual income statement, balance sheet and cash flow for Anondita Medi (ANONDITA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Anondita Medi

Loading latest quarterly results...

About ANONDITA (Anondita Medi)

Anondita Medi (ANONDITA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Personal Care sector with a current ma...rket capitalisation of ₹2.14K (Cr). Anondita Medi has delivered a Return on Equity (ROE) of 40.03% and a ROCE of 43.60%. The debt-to-equity ratio stands at 0.26, reflecting the company's capital structure. Investors tracking ANONDITA share price can monitor key metrics including P/E ratio, promoter holding of 62.40%, and quarterly earnings growth.

Company Details

Symbol:ANONDITA
Industry:Personal Care
Sector:Personal Care
Website:N/A

ANONDITA Share Price: Frequently Asked Questions

What is the current share price of Anondita Medi?

Anondita Medi (ANONDITA) trades at ₹1084.60 on NSE. Market cap ₹2.14K (Cr). Educational data only.

What is the P/E ratio of Anondita Medi?

Anondita Medi has a P/E of 63.95x vs industry average 40.63x.

What is the Bull Run score for Anondita Medi?

Anondita Medi has a Bull Run score of 44.6/100 based on 25+ financial parameters.

Does Anondita Medi pay dividends?

Anondita Medi has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Anondita Medi?

Anondita Medi has ROE of 40.03%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Anondita Medi?

Anondita Medi has debt-to-equity of 0.26.

Is Anondita Medi a good investment?

Bull Run gives Anondita Medi a score of 44.6/100. This is not investment advice — consult a SEBI-registered advisor.